Immuron Limited (IMRN)
NASDAQ: IMRN · Real-Time Price · USD
0.9535
+0.0042 (0.44%)
At close: Oct 23, 2026, 4:00 PM EDT
0.9320
-0.0215 (-2.25%)
After-hours: Oct 23, 2026, 6:44 PM EDT
Immuron Market Cap
Immuron has a market cap or net worth of $9.06 million as of October 23, 2026. Its market cap has decreased by 31.35% in one year.
Market Cap
9.06M
Enterprise Value
2.87M
1-Year Change
-31.35%
Global Rank
n/a
Country Rank
n/a
Category
ChartMarket Cap Chart
Since June 9, 2017, Immuron's market cap has decreased from $28.10M to $9.06M, a decrease of -67.75%. That is a compound annual growth rate of -11.37%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 22, 2026 | 7.70M | 71.11% |
| Dec 31, 2025 | 4.50M | -53.61% |
| Dec 31, 2024 | 9.70M | -9.35% |
| Dec 29, 2023 | 10.70M | -9.32% |
| Dec 30, 2022 | 11.80M | -16.90% |
| Dec 31, 2021 | 14.20M | -50.00% |
| Dec 31, 2020 | 28.40M | 91.89% |
| Dec 31, 2019 | 14.80M | -28.50% |
| Dec 31, 2018 | 20.70M | 20.35% |
| Dec 29, 2017 | 17.20M | -38.79% |
| Jun 9, 2017 | 28.10M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Adial Pharmaceuticals | 10.29M |
| Phio Pharmaceuticals | 9.90M |
| GT Biopharma | 9.85M |
| BioVie | 9.35M |
| Ensysce Biosciences | 9.15M |
| MetaVia | 9.09M |
| Theriva Biologics | 8.99M |
| Lisata Therapeutics | 8.97M |